N22566
yw30f06.s1 Morton Fetal Cochlea Homo sapiens cDNA clone IMAGE:253763 3', mRNA sequence.
584
mRNA
Homo sapiens
DJ151946
JP 2007228956-A/22564: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
MC164410
JP 2019500349-A/22566: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
MC551066
JP 2019525738-A/22566: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
5
PRT
synthetic construct
MD754808
JP 2019507579-A/22566: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
OG506752
JP 2018534252-A/22566: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
32
PRT
synthetic construct
HZ527347
JP 2016501039-A/22566: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
MD268699
JP 2020517247-A/22566: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
DL904310
JP 2014205669-A/22566: Method of constructing and screening libraries of peptide structures.
26
PRT
synthetic construct
MC774676
JP 2018525446-A/22566: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
34
PRT
synthetic construct
DJ952927
JP 2010500568-A/39608: ORGAN-SPECIFIC PROTEINS AND METHODS OF THEIR USE.
653
PRT
Homo sapiens
MC906304
JP 2018536623-A/22566: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
39
PRT
synthetic construct
DM759260
JP 2014079248-A/22566: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
PA527050
JP 2022502046-A/9832: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
PA393289
JP 2021533803-A/22372: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
PA338214
JP 2021522188-A/22566: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
MB763499
JP 2018535655-A/27396: ASGR INHIBITORS.
8
PRT
synthetic construct
OG752085
JP 2021120380-A/22566: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
DJ526366
JP 2010517930-A/22566: Method of constructing and screening libraries of peptide structures.
26
PRT
synthetic construct
DM797024
JP 2014068652-A/22566: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
PD710480
JP 2021530475-A/22562: De novo Design of Protein Switches.
59
PRT
synthetic construct
LF829722
JP 2016528161-A/22555: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
LF681787
JP 2016521556-A/22566: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
DD549169
JP 2004508801-A/22566: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
DL031580
JP 2005512499-A/22566: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
588
DNA
synthetic construct
LV568388
JP 2017029159-A/22566: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
HW187594
JP 2013102767-A/22518: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
DL613168
JP 2011092200-A/22566: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
HV879107
JP 2010507387-A/22518: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
LX120182
JP 2017506877-A/22564: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct